Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
This trial has been terminated.
|Start date||February 2011|
|End date||December 2013|
|Trial size||40 participants|
|Trial identifier||NCT01299441, 10-007600|
The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
Patients undergoing liver transplantation and intubated with ECOM endotracheal tube (ETT).
endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive
time frame: Less than 24 hours
All participants from 18 years up to 99 years old.
Inclusion Criteria: - Patients undergoing liver transplantation surgery Exclusion Criteria: - Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.
|Official title||Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation|
|Principal investigator||Timothy Shine, MD|
Call for more information